Eradikation des Hepatitis C Virus bei Dialysepatienten mit Grazoprevir und Elbasvir

Translated title of the contribution: Grazoprevir plus elbasvir in treatmentnaive and treatment-experienced patient with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): A combination phase 3 study

David Roth, D. R. Nelson, A. Bruchfeld, A. Liapakis, M. Silva, H. Monsour, P. Martin, S. Pol, M. C. Londoño, T. Hassanein, P. J. Zamor, E. Zuckerman, S. Wan, B. Jackson, B. Y. Nguyen, M. Robertson, E. Barr, J. Wahl, W. Greaves

Research output: Contribution to journalShort survey

Translated title of the contributionGrazoprevir plus elbasvir in treatmentnaive and treatment-experienced patient with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): A combination phase 3 study
Original languageGerman
Pages (from-to)178-179
Number of pages2
JournalNieren- und Hochdruckkrankheiten
Volume45
Issue number4
StatePublished - Apr 1 2016

ASJC Scopus subject areas

  • Internal Medicine
  • Nephrology

Cite this

Roth, D., Nelson, D. R., Bruchfeld, A., Liapakis, A., Silva, M., Monsour, H., Martin, P., Pol, S., Londoño, M. C., Hassanein, T., Zamor, P. J., Zuckerman, E., Wan, S., Jackson, B., Nguyen, B. Y., Robertson, M., Barr, E., Wahl, J., & Greaves, W. (2016). Eradikation des Hepatitis C Virus bei Dialysepatienten mit Grazoprevir und Elbasvir. Nieren- und Hochdruckkrankheiten, 45(4), 178-179.